News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
72,684 Results
Type
Article (6039)
Company Profile (17)
Press Release (66626)
Multimedia
Podcasts (5)
Webinars (4)
Section
Business (21197)
Career Advice (290)
Deals (3333)
Drug Delivery (18)
Drug Development (5580)
Employer Resources (27)
FDA (1426)
Job Trends (2050)
News (31470)
Policy (2609)
Tag
Academia (631)
Accelerated approval (4)
Adcomms (1)
Allergies (13)
Alliances (6318)
ALS (13)
Alzheimer's disease (229)
Antibody-drug conjugate (ADC) (38)
Approvals (1424)
Artificial intelligence (139)
Autoimmune disease (19)
Automation (23)
Bankruptcy (30)
Best Places to Work (1492)
BIOSECURE Act (3)
Biosimilars (35)
Biotechnology (8)
Bladder cancer (16)
Brain cancer (9)
Breast cancer (82)
Cancer (698)
Cardiovascular disease (52)
Career advice (257)
Career pathing (12)
CAR-T (38)
CDC (9)
Cell therapy (104)
Cervical cancer (17)
Clinical research (4453)
Collaboration (271)
Compensation (11)
Complete response letters (3)
COVID-19 (541)
CRISPR (17)
C-suite (96)
Cystic fibrosis (14)
Data (860)
Denatured (1)
Depression (21)
Diabetes (37)
Diagnostics (1975)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (55)
Drug pricing (18)
Drug shortages (2)
Duchenne muscular dystrophy (26)
Earnings (6969)
Editorial (12)
Employer branding (3)
Employer resources (25)
Events (7959)
Executive appointments (120)
FDA (1718)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (251)
Gene editing (35)
Generative AI (12)
Gene therapy (72)
GLP-1 (113)
Government (586)
Grass and pollen (1)
Guidances (49)
Healthcare (2006)
HIV (8)
Huntington's disease (6)
IgA nephropathy (8)
Immunology and inflammation (30)
Immuno-oncology (11)
Indications (12)
Infectious disease (592)
Inflammatory bowel disease (21)
Inflation Reduction Act (4)
Influenza (37)
Intellectual property (19)
Interviews (37)
IPO (1275)
IRA (6)
Job creations (560)
Job search strategy (216)
JPM (14)
Kidney cancer (1)
Labor market (28)
Layoffs (62)
Leadership (15)
Legal (426)
Liver cancer (2)
Longevity (4)
Lung cancer (87)
Lymphoma (62)
Machine learning (15)
Management (6)
Manufacturing (131)
MASH (14)
Medical device (1284)
Medtech (1293)
Mergers & acquisitions (2171)
Metabolic disorders (121)
Multiple sclerosis (15)
Neurodegenerative disease (35)
Neuropsychiatric disorders (12)
Neuroscience (380)
Neurotech (1)
NextGen: Class of 2026 (850)
Non-profit (674)
Now hiring (23)
Obesity (73)
Opinion (79)
Ovarian cancer (18)
Pain (25)
Pancreatic cancer (33)
Parkinson's disease (38)
Partnered (11)
Patents (30)
Patient recruitment (40)
Peanut (7)
People (6296)
Pharmaceutical (2)
Phase 1 (1555)
Phase 2 (2099)
Phase 3 (1463)
Pipeline (731)
Policy (50)
Postmarket research (128)
Preclinical (820)
Press Release (24)
Prostate cancer (40)
Psychedelics (7)
Radiopharmaceuticals (22)
Rare diseases (91)
Real estate (1497)
Recruiting (15)
Regulatory (2041)
Reports (17)
Research institute (609)
Resumes & cover letters (35)
Rett syndrome (5)
RNA editing (1)
RSV (12)
Schizophrenia (16)
Series A (45)
Series B (25)
Service/supplier (2)
Sickle cell disease (6)
Special edition (7)
Spinal muscular atrophy (9)
Sponsored (11)
Startups (572)
Stomach cancer (1)
Supply chain (13)
Tariffs (9)
The Weekly (4)
Vaccines (97)
Venture capital (31)
Weight loss (46)
Women's health (10)
Worklife (5)
Date
Last 7 days (69)
Last 30 days (251)
Last 365 days (3563)
2026 (318)
2025 (3673)
2024 (4370)
2023 (4553)
2022 (6504)
2021 (7084)
2020 (7288)
2019 (5227)
2018 (3784)
2017 (3661)
2016 (3737)
2015 (3857)
2014 (2619)
2013 (2247)
2012 (2413)
2011 (2501)
2010 (1915)
Location
Africa (131)
Alabama (13)
Alaska (1)
Arizona (34)
Arkansas (3)
Asia (4234)
Australia (596)
California (1241)
Canada (369)
China (185)
Colorado (54)
Connecticut (104)
Delaware (26)
Europe (8986)
Florida (105)
Georgia (37)
Idaho (10)
Illinois (90)
India (18)
Indiana (72)
Iowa (8)
Japan (41)
Kansas (7)
Kentucky (5)
Louisiana (6)
Maine (6)
Maryland (132)
Massachusetts (865)
Michigan (90)
Minnesota (66)
Mississippi (2)
Missouri (31)
Montana (4)
Nebraska (5)
Nevada (12)
New Hampshire (10)
New Jersey (297)
New Mexico (11)
New York (393)
North Carolina (150)
North Dakota (3)
Northern California (600)
Ohio (67)
Oklahoma (3)
Oregon (9)
Pennsylvania (240)
Puerto Rico (1)
Rhode Island (6)
South America (221)
South Carolina (9)
Southern California (459)
Tennessee (42)
Texas (222)
United States (4495)
Utah (60)
Virginia (26)
Washington D.C. (6)
Washington State (98)
West Virginia (2)
Wisconsin (21)
72,684 Results for "notable labs".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Notable Labs Reports 2023 Financial Results and Provides a Business Update
Notable Labs, Ltd. reported financial results for the year ended December 31, 2023 and provided a business update.
April 12, 2024
·
9 min read
Biotech Bay
Notable Labs to Participate in JMP Securities Hematology and Oncology Summit
Notable Labs, Ltd. (“Notable”) (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, today announced that Thomas Bock, M.D., CEO of Notable Labs, will participate in a fireside chat at the JMP Securities Hematology and Oncology Summit taking place virtually on December 5 – 6, 2023.
December 4, 2023
·
1 min read
Biotech Bay
Notable Labs to Present Two Posters at AACR 2024 on PPMP Platform
Notable Labs, Ltd. announced that the Company will present two posters related to its PPMP platform at the American Association for Cancer Research Annual Meeting 2024, taking place April 5-10, 2024 in San Diego, CA.
March 5, 2024
·
6 min read
Press Releases
Notable Labs Announces CEO Transition
August 27, 2024
·
7 min read
Press Releases
EVQLV Launches Abtique, the First Marketplace for AI-Designed Molecules Validated in Independent Labs
New “click-to-sequence” platform lets researchers buy AI-designed antibody sequences online, using an AI system that learns from real lab results
November 20, 2025
·
1 min read
Deals
Notable Labs Closes Merger Transaction With VBL Therapeutics
Notable Labs, Inc., a clinical stage therapeutic platform company developing predictive precision medicines for cancer patients, announced the completion of its merger transaction with VBL Therapeutics and associated financing.
October 16, 2023
·
9 min read
Drug Development
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable” or the “Company”) today presented the design for the PPMP-enabled Phase 2 trial with volasertib, in combination with decitabine, in patients with relapsed/refractory (R/R) acute myeloid leukemia (AML) at the American Association for Cancer Research (AACR 2024) being held in San Diego, CA (Poster abstract 5178).
April 9, 2024
·
8 min read
Business
Notable Labs Announces Filing of Form 10-Q for Third Quarter 2023
Notable Labs, Ltd. announced that it has filed its Quarterly Report on Form 10-Q containing financial results for the third quarter and nine months ended September 30, 2023.
November 14, 2023
·
5 min read
Drug Development
Notable Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment
Notable Labs, Ltd. (Nasdaq: NTBL) (“Notable”, “Notable Labs”) today announced the advancement of its volasertib Phase 2 program utilizing PPMP to enrich the study population for clinical responders.
February 22, 2024
·
8 min read
Biotech Bay
Notable Labs Presentation of Data Related to Innovations in the Use of Cryopreserved Samples in the PPMP Assay at AACR 2024 Expands the Potential of the Platform
Notable Labs, Ltd., a clinical-stage precision oncology company developing a new class of cancer therapies identified by its Predictive Precision Medicine Platform, presented data related to innovations in the use of cryopreserved samples in the PPMP assay at the American Association for Cancer Research being held in San Diego, CA.
April 8, 2024
·
8 min read
1 of 7,269
Next
